TipRanks
Go Ultimate55% OFF

Lexeo Therapeutics, Inc. (LXEO) Cash flow

Lexeo Therapeutics, Inc. Cash Flow

LXEO's free cash flow for Q2 2026 was $-17.60M. For the 2026 fiscal year, LXEO's free cash flow was decreased by $-7.00K and operating cash flow was $-17.60M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -98.56M$ -81.15M$ -59.50M$ -54.56M$ -44.18M
$ -90.25M$ -94.08M$ -165.00K$ -901.00K$ -188.00K
$ 216.79M$ 88.78M$ 103.79M$ 189.00K$ 150.86M
$ 66.25M$ 38.27M$ 124.72M$ 80.59M$ 135.86M
$ -98.96M$ -81.63M$ -59.66M$ -55.46M$ -44.37M

Currency in USD

Lexeo Therapeutics, Inc. Cash Flow

-200M-100M0100M200M300M202020212022202320242025OperatingInvestingFinancing